Lucid Diagnostics Inc Live Share Price Today, Share Analysis and Chart

Name: Lucid Diagnostics Inc: Is Infosys Ltd. worth buying?
Item: Lucid Diagnostics Inc
Rating: 1.39666675
Author: Trendlyne DVM scores

about

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of dev...

1.14 0.05 (4.59%)

36.67% Fall from 52W High

1.2M

XNAS Volume

XNAS 17 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

1.2 / 100

Technically Neutral

54.7 / 100

1Yr Price target upside is 232%

6 analysts

Lucid Diagnostics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lucid Diagnostics Inc Live Share Price Today, Share Analysis and Chart

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of dev...

36.67% Fall from 52W High

SWOT Analysis

Lucid Diagnostics Inc Live Price Chart